• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Coverage for Emerging Technologies - Bridging Regulatory Approval and Patient Access.

作者信息

Kadakia Kushal T, Kramer Daniel B, Yeh Robert W

机构信息

From Harvard Medical School (K.T.K., D.B.K., R.W.Y.) and the Richard A. and Susan F. Smith Center for Outcomes Research, Beth Israel Deaconess Medical Center (D.B.K., R.W.Y.) - both in Boston.

出版信息

N Engl J Med. 2023 Nov 30;389(22):2021-2024. doi: 10.1056/NEJMp2308736. Epub 2023 Nov 25.

DOI:10.1056/NEJMp2308736
PMID:38009607
Abstract
摘要

相似文献

1
Coverage for Emerging Technologies - Bridging Regulatory Approval and Patient Access.新兴技术的覆盖范围——弥合监管审批与患者可及性之间的差距。
N Engl J Med. 2023 Nov 30;389(22):2021-2024. doi: 10.1056/NEJMp2308736. Epub 2023 Nov 25.
2
Alignment in post-approval changes (PAC) guidelines in emerging countries may increase timely access to vaccines: An illustrative assessment by manufacturers.新兴国家批准后变更（PAC）指南中的一致性可能会增加疫苗的及时可及性：制造商的实例评估。
Vaccine X. 2020 Aug 25;6:100075. doi: 10.1016/j.jvacx.2020.100075. eCollection 2020 Dec 11.
3
Advanced Medical Care Program for the Rapid Introduction of Healthcare Technologies to the National Health Insurance System in Japan.日本医疗技术快速纳入国民健康保险制度的高级医疗保障计划。
Clin Transl Sci. 2020 Jul;13(4):700-706. doi: 10.1111/cts.12751. Epub 2020 Feb 27.
4
Bridging Gaps in Oncology: Comparative Analysis of Development and Approval Pathways for Anticancer Drugs and Companion Diagnostic in the United States and Japan.弥合肿瘤学差距：美国和日本抗癌药物及伴随诊断试剂的研发与审批途径对比分析
Clin Transl Sci. 2025 Feb;18(2):e70162. doi: 10.1111/cts.70162.
5
From Regulatory Approval to Subsidized Patient Access in the Asia-Pacific Region: A Comparison of Systems Across Australia, China, Japan, Korea, New Zealand, Taiwan, and Thailand.从监管批准到亚太地区的患者补贴获取：澳大利亚、中国、日本、韩国、新西兰、台湾地区和泰国的系统比较。
Value Health Reg Issues. 2015 May;6:40-45. doi: 10.1016/j.vhri.2015.03.013. Epub 2015 May 16.
6
Coverage of Novel Therapeutic Agents by Medicare Prescription Drug Plans Following FDA Approval.医疗保险处方药计划在 FDA 批准后对新治疗药物的覆盖范围。
J Manag Care Spec Pharm. 2018 Dec;24(12):1230-1238. doi: 10.18553/jmcp.2018.24.12.1230.
7
Interactions between health technology assessment, coverage, and regulatory processes: emerging issues, goals, and opportunities.卫生技术评估、覆盖范围和监管流程之间的相互作用：新出现的问题、目标和机会。
Int J Technol Assess Health Care. 2011 Jul;27(3):253-60. doi: 10.1017/S0266462311000262.
8
A Comprehensive Algorithm for Approval of Health Technologies With, Without, or Only in Research: The Key Principles for Informing Coverage Decisions.一种用于有、无或仅在研究中使用的卫生技术批准的综合算法：为覆盖决策提供信息的关键原则
Value Health. 2016 Sep-Oct;19(6):885-891. doi: 10.1016/j.jval.2016.03.2003. Epub 2016 May 11.
9
Improving Food and Drug Administration-Centers for Medicare and Medicaid Services Coordination for Drugs Granted Accelerated Approval.改进食品药品监督管理局与医疗保险和医疗补助服务中心对加速批准药物的协调。
Milbank Q. 2023 Dec;101(4):1047-1075. doi: 10.1111/1468-0009.12670. Epub 2023 Aug 29.
10
Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval.英格兰对有资格获得美国食品和药物管理局加速批准的癌症药物的覆盖范围评估。
JAMA Intern Med. 2021 Apr 1;181(4):490-498. doi: 10.1001/jamainternmed.2020.8441.

引用本文的文献

1
CORE-MD clinical risk score for regulatory evaluation of artificial intelligence-based medical device software.用于基于人工智能的医疗设备软件监管评估的CORE-MD临床风险评分
NPJ Digit Med. 2025 Feb 6;8(1):90. doi: 10.1038/s41746-025-01459-8.
2
Digital Health for Asthma Management: Electronic Medication Monitoring for Adherence as a Case Example.用于哮喘管理的数字健康：以电子药物监测依从性为例
J Allergy Clin Immunol Pract. 2025 Jul;13(7):1518-1526. doi: 10.1016/j.jaip.2024.12.042. Epub 2025 Jan 15.